Articles from Agiliti, Inc.

Agiliti, a leading manufacturer and provider of medical device solutions to the U.S. healthcare industry, today announced its exclusive agreement with VitalGo Systems Ltd., to become the exclusive U.S. provider of the Total Lift Bed® (TLB). This agreement builds on Agiliti’s portfolio of solutions for the ICU where the company is supporting hospitals in the early mobilization of critically ill patients to reduce length of stay and improve care outcomes.

Agiliti, a leading manufacturer and provider of medical device solutions to the U.S. healthcare industry, today announced the launch of Capillaire™, a low-profile alternating air pressure support surface that delivers dynamic pressure redistribution, clinically proven to prevent and treat perioperative pressure injuries (PI) in surgeries lasting longer than two hours. The unique and dynamic overlay is compatible with most operating room (OR) tables and stretcher platforms across surgical, perioperative and emergency care environments.

Agiliti, a leading manufacturer and provider of medical device solutions to the U.S. healthcare industry, has expanded its oncology offerings to physicians and hospitals, providing greater value and access to focal therapy services for diagnosing and treating prostate cancer.

Agiliti, a leading manufacturer and provider of medical device solutions to the U.S. healthcare industry, today announced the launch of its new NP Line™ of stretcher support surfaces clinically engineered for safer patient care.

Agiliti, a leading manufacturer and provider of medical device solutions to the U.S. healthcare industry, announced today it will showcase its newly launched Essentia™ hospital bed and Adapt Line™ suite of therapeutic hospital support surfaces at the American Organization of Nursing Leadership (AONL) Conference, March 30 – April 2, 2025, in Boston.

Agiliti, a leading manufacturer and provider of medical device solutions to the U.S. healthcare industry, today announced the launch of Essentia™, a versatile, multi-acuity bed frame designed to support a wide range of patients across different hospital settings. Essentia offers caregivers the flexibility to tailor care based on patient risk profiles and features proprietary safety capabilities – including the first-of-its-kind SlideRail™ – to help accelerate patient mobility and reduce risk to caregivers.

Agiliti, a nationwide manufacturer and provider of medical device solutions to the healthcare industry, today announced the launch of its Adapt Line™ of therapeutic hospital support surfaces, clinically engineered to enhance patient comfort and help reduce the risk of pressure injuries resulting from prolonged bed rest.

Agiliti Inc. (NYSE: AGTI) (“Agiliti”), a nationwide provider of medical technology management and service solutions to the healthcare industry, today announced the closing of its acquisition by an affiliate of private equity firm Thomas H. Lee Partners, L.P. (“THL”).

Agiliti Inc. (NYSE: AGTI) (“Agiliti”), a nationwide provider of medical technology management and service solutions to the healthcare industry, today announced that it has entered into a definitive merger agreement pursuant to which an affiliate of private equity firm Thomas H. Lee Partners, L.P. (“THL”), the company’s majority shareholder, will acquire all outstanding shares of Agiliti common stock not currently owned by THL and its affiliates and certain management shareholders for $10.00 per share in cash, implying an enterprise value of approximately $2.5 billion.

Agiliti Inc. (NYSE: AGTI) (“Agiliti”) today announced that the company will release its fourth quarter and full year 2023 financial results after the market close on Tuesday, March 5, 2024, to be followed by a conference call at 5 p.m. Eastern Time on the same day.

Agiliti Inc. (NYSE: AGTI) (“Agiliti”), a nationwide provider of healthcare technology management and service solutions to the healthcare industry, today announced its financial results for the third quarter ended September 30, 2023, and reaffirmed its financial outlook for the full year.

Agiliti, Inc. (NYSE: AGTI) (“Agiliti”), a nationwide provider of medical technology management and service solutions to the healthcare industry, today announced that the Agiliti Board of Directors has appointed Tom Leonard as Chief Executive Officer. Leonard succeeds Tom Boehning who is no longer with the company.

Agiliti Inc. (NYSE: AGTI) (“Agiliti”) today announced that the company will participate at the Morgan Stanley Global Healthcare Conference on September 12, 2023, in New York City.

Agiliti Inc. (NYSE: AGTI) (“Agiliti”), a nationwide provider of healthcare technology management and service solutions to the United States healthcare industry, today announced that its board of directors approved a share repurchase program that grants the Company authority to repurchase up to $50 million of shares of the Company’s common stock (exclusive of any fees, commissions or other expenses related to such repurchases), over a 12-month period.

Agiliti Inc. (NYSE: AGTI) (“Agiliti”) today announced that it received the HealthTrust Performance Group’s Clinical Supplier of the Year Award at the 2023 HealthTrust University Conference in Las Vegas.

Agiliti Inc. (NYSE: AGTI) (“Agiliti”) today announced that the company will release its second quarter 2023 financial results after the market close on Tuesday, August 8, 2023, to be followed by a conference call at 5 p.m. Eastern Time on the same day.

Agiliti Inc. (NYSE: AGTI) (“Agiliti”) today announced that the company will participate at the UBS Healthcare Services Conference, June 27-28, 2023, in Chatham, Mass. Management will host 1x1 investor meetings on both days. Investors who are interested in setting up a meeting may contact Agiliti Investor Relations or their UBS conference representatives.

Agiliti Inc. (NYSE: AGTI) (“Agiliti”) today announced that the company will participate at the Bank of America 2023 Health Care Conference on May 10, 2023, in Las Vegas, Nevada.

Agiliti Inc. (NYSE: AGTI) (“Agiliti”) today announced that the company will release its first quarter 2023 financial results after the market close on Tuesday, May 9, 2023, to be followed by a conference call at 5 p.m. Eastern Time on the same day.

Agiliti Inc. (NYSE: AGTI) (“Agiliti”) today announced that the company will participate at the KeyBanc Life Sciences & MedTech Investor Forum on March 22, 2023.

Agiliti Inc. (NYSE: AGTI) (“Agiliti”), a nationwide provider of healthcare technology management and service solutions to the United States healthcare industry, today announced its financial results for the fourth quarter and year ended December 31, 2022, and provided its financial outlook for 2023.

Agiliti, Inc. (NYSE: AGTI) (“Agiliti”) today announced that the company will release its fourth quarter and full year 2022 financial results after the market close on Tuesday, March 7, 2023, to be followed by a conference call at 5 p.m. Eastern Time on the same day.

Agiliti, Inc. (NYSE: AGTI) (“Agiliti”), a nationwide provider of medical technology management and service solutions to the United States healthcare industry, today announced that Tom Leonard will retire as Agiliti CEO on March 10, 2023, and continue on as a member of the company’s Board of Directors. Tom Boehning, currently President, will succeed Leonard as Chief Executive Officer and join the Agiliti Board of Directors beginning March 10, 2023. Mr. Leonard will remain an employee of the Company to assist with the transition of his executive responsibilities to Mr. Boehning until March 31, 2023.

Agiliti Inc. (NYSE: AGTI) (“Agiliti”), a nationwide provider of healthcare technology management and service solutions to the United States healthcare industry, today announced its financial results for the quarter ended September 30, 2022, and revised its full-year financial guidance.

Agiliti Inc. (NYSE: AGTI) (“Agiliti”), a nationwide provider of healthcare technology management and service solutions to the United States healthcare industry, today announced its financial results for the quarter ended June 30, 2022, and reaffirmed its full-year financial guidance with results expected at the lower end of its range.

Agiliti Inc. (NYSE: AGTI) (“Agiliti”) today announced that the company will release its second quarter results after the market close on Tuesday, August 9, 2022, to be followed by a conference call at 5 p.m. Eastern Time on the same day.

Agiliti Inc. (NYSE: AGTI) (“Agiliti”), a nationwide provider of healthcare technology management and service solutions to the United States healthcare industry, today announced its financial results for the quarter ended March 31, 2022, and reaffirmed its financial outlook for 2022.

Agiliti Inc. (NYSE: AGTI) (“Agiliti”) today announced that the company will participate at the following investor conferences:

Agiliti Inc. (NYSE: AGTI) (“Agiliti”) today announced that the company will release its first quarter results after the market close on Tuesday, May 10, 2022, to be followed by a conference call at 5 p.m. Eastern Time on the same day.

Agiliti Inc. (NYSE: AGTI) (“Agiliti”) today announced that the company will participate at the KeyBanc Life Sciences & MedTech Investor Forum on March 22, 2022.

Agiliti Inc. (NYSE: AGTI) (“Agiliti”) today announced that the company will release its fourth quarter and full year results after the market close on Tuesday, March 8, 2022, to be followed by a conference call at 5 p.m. Eastern Time on the same day.

Agiliti Inc. (NYSE: AGTI) (“Agiliti”), a nationwide provider of healthcare technology management and service solutions to the United States healthcare industry, today announced its financial results for the quarter ended September 30, 2021, and raised its full-year guidance for 2021.

Agiliti Inc. (NYSE: AGTI) (“Agiliti”) today announced that the company will release its third quarter results after the market close on Tuesday, November 9, 2021, to be followed by a conference call at 5 p.m. Eastern Time on the same day.

Agiliti, Inc. (NYSE: AGTI) (“Agiliti” or “the Company”), an essential service provider to the U.S. healthcare industry, today announced that it has completed the previously announced acquisition of Sizewise Rentals, LLC, (“Sizewise”), a manufacturer and distributor of specialty hospital beds, surfaces and patient handling equipment.

Agiliti, Inc. (NYSE: AGTI) (“Agiliti” or “the Company”), an essential service provider to the U.S. healthcare industry, today announced that it has entered into a definitive agreement to acquire Sizewise Rentals, LLC, (“Sizewise”), a manufacturer and distributor of specialty hospital beds, surfaces and patient handling equipment, in a stock purchase transaction valued at $230 million or approximately 7.7x Adjusted EBITDA for the twelve months ended June 30, 2021. Agiliti intends to finance the transaction through a combination of cash and debt. The Boards of Directors of both companies have unanimously approved the agreement. Subject to the satisfaction of customary closing conditions, the transaction is expected to close early in the fourth quarter of 2021. Following the close of the transaction, Agiliti will provide an update to its full year 2021 financial guidance at the time it reports quarterly results for the period ending September 30, 2021.

Agiliti, Inc. (NYSE: AGTI) (“Agiliti”), a nationwide provider of healthcare technology management and service solutions to the United States healthcare industry, today announced its financial results for the quarter ended June 30, 2021, and raised its full-year guidance for 2021.

Agiliti Inc. (NYSE: AGTI) (“Agiliti”) today announced that the company will release its second quarter results after the market close on Thursday, August 12, 2021, to be followed by a conference call at 5 p.m. Eastern Time on the same day.

Agiliti Inc. (NYSE: AGTI) (“Agiliti”), a nationwide provider of healthcare technology management and service solutions, today announced that the company will participate at the Goldman Sachs 42nd Annual Global Healthcare Conference.

Agiliti Inc. (NYSE: AGTI) (“Agiliti”), a nationwide provider of healthcare technology management and service solutions to the United States healthcare industry, today announced its financial results for the quarter ended March 31, 2021, and provided a preliminary outlook for the full year 2021.

Agiliti, Inc. (NYSE:AGTI) (“Agiliti”), an essential service provider to the U.S. healthcare industry, today announced the pricing of its underwritten initial public offering of 26,315,789 shares of common stock at a price to the public of $14 per share. In connection with this offering, Agiliti has granted the underwriters a 30-day option to purchase up to an additional 3,947,368 shares of common stock at the initial public offering price less the underwriting discount. The shares are expected to begin trading on the New York Stock Exchange on April 23, 2021 under the symbol “AGTI.” The initial public offering is expected to close on April 27, 2021, subject to the satisfaction of customary closing conditions.